EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro and in silico studies for the identification of anti-cancer and antibacterial peptides from camel milk protein hydrolysates

Mohammad Javad Taghipour, Hamid Ezzatpanah iD, Mohammad Ghahderijani

PLOS ONE · 12.07.2023 · 18 (7) · e0288260

DOI: 10.1371/journal.pone.0288260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 12.07.2023. Verfasst von Mohammad Javad Taghipour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Technology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Camelus, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Today, breast cancer and infectious diseases are very worrying that led to a widespread effort by researchers to discover natural remedies with no side effects to fight them. In the present study, we isolated camel milk protein fractions, casein and whey proteins, and hydrolyzed them using pepsin, trypsin, and both enzymes. Screening of peptides with anti-breast cancer and antibacterial activity against pathogens was performed. Peptides derived from whey protein fraction with the use of both enzymes showed very good activity against MCF-7 breast cancer with cell viability of 7.13%. The separate use of trypsin and pepsin to digest whey protein fraction yielded peptides with high antibacterial activity against S . aureus (inhibition zone of 4.17 ± 0.30 and 4.23 ± 0.32 cm, respectively) and E . coli (inhibition zone of 4.03 ± 0.15 and 4.03 ± 0.05 cm, respectively). Notably, in order to identify the effective peptides in camel milk, its protein sequences were retrieved and enzymatically digested in silico . Peptides that showed both anticancer and antibacterial properties and the highest stability in intestinal conditions were selected for the next step. Molecular interaction analysis was performed on specific receptors associated with breast cancer and/or antibacterial activity using molecular docking. The results showed that P3 (WNHIKRYF) and P5 (WSVGH) peptides had low binding energy and inhibition constant so that they specifically occupied active sites of protein targets. Our results introduced two peptide-drug candidates and new natural food additive that can be delivered to further animal and clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CamelusNeoplasmsAnimalsProtein HydrolysatesEscherichia coliMolecular Docking SimulationPepsin AStaphylococcus aureusTrypsinWhey ProteinsPeptidesAnti-Bacterial Agents

Substanzen

Protein HydrolysatesPepsin ATrypsinWhey ProteinsPeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Food Science and Technology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Department of Agricultural Systems Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.

ORCID-Profile: Hamid Ezzatpanah

Zitieren

APA

Taghipour, M. J., Ezzatpanah, H., & Ghahderijani, M. (2023). In vitro and in silico studies for the identification of anti-cancer and antibacterial peptides from camel milk protein hydrolysates. PLOS ONE, 18(7), e0288260. https://doi.org/10.1371/journal.pone.0288260

Vancouver

Taghipour MJ, Ezzatpanah H, Ghahderijani M. In vitro and in silico studies for the identification of anti-cancer and antibacterial peptides from camel milk protein hydrolysates. PLOS ONE. 2023;18(7):e0288260. doi:10.1371/journal.pone.0288260

BibTeX
@article{Taghipour2023,
  author = {Taghipour, Mohammad Javad and Ezzatpanah, Hamid and Ghahderijani, Mohammad},
  title = {In vitro and in silico studies for the identification of anti-cancer and antibacterial peptides from camel milk protein hydrolysates},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {7},
  pages = {e0288260},
  doi = {10.1371/journal.pone.0288260}
}
Kostenlos starten →